FDA Grand Rounds: Prohibiting Menthol in Tobacco Products

Jan.13.2023
FDA Grand Rounds: Prohibiting Menthol in Tobacco Products
FDA proposes ban on menthol as a characterizing flavor in cigarettes and cigars to prevent youth from smoking.

On January 12, 2023 at 12:00 Eastern Time, the FDA held an online seminar open to the public regarding the proposed ban on menthol cigarettes. The seminar was called "FDA Grand Rounds: The Scientific Basis of Proposed Tobacco Product Standards to Prohibit Menthol as a Characterizing Flavor in Cigarettes and Flavors in Cigars." The purpose of the seminar was to discuss the scientific reasoning behind the proposal for a ban on menthol flavoring in tobacco products.


The 2FIRSTS staff participated in this lecture through online means and compiled the key information below based on the conference content.


Bridget Ambrose, director of the Population Health Sciences Division at the FDA's Center for Tobacco Products Science Office, served as a spokesperson. She explained the scientific reasoning behind the FDA's proposed ban on menthol-flavored cigarettes in several ways:


FDA Lecture Presentation Source: FDA


The contents of this page's PPT are as follows in standard journalistic English:


The health problems caused by smoking and the role of flavoring in tobacco products, specifically the use of menthol in cigarettes and cigars, are topics currently under scientific study and peer review by the FDA.


Bridget Ambrose believes that adding flavors to cigarettes can enhance the smoking experience and increase the appeal of cigarettes to users, thereby encouraging people, especially teenagers, to smoke. She cited several research papers to support her viewpoint.


Source: FDA


Therefore, on April 28, 2022, the FDA introduced two draft proposals concerning the prohibition of menthol additives in cigarettes and cigars. Ambrose stated that some regions have already banned the sale of flavored and menthol-flavored cigarettes (as seen in the image below, and detailed in 2FIRSTS reports).


Source: FDA


In addition, Ambrose presented peer-reviewed findings to demonstrate the scientific validity of the FDA's research and stated that banning menthol would be beneficial for smokers who want to quit.


How will the ban on menthol cigarettes impact the tobacco market in the United States?


The United States Tobacco Control Act was first proposed in 2009, granting the FDA the authority to regulate tobacco products at the federal level. The recent proposal to ban menthol cigarettes is the latest development in the US's tobacco control efforts, with even stricter regulations than the previously imposed flavor bans.


Back in 2009, when the Tobacco Control Act was introduced, the FDA announced a ban on flavored cigarettes, including mint, but not menthol. This is because mint flavor is one of the tobacco flavors, while menthol is a natural extract from mint. Menthol-added cigarettes provide a cooling sensation but do not alter the taste. This is the difference between mint flavor and menthol. Therefore, by banning menthol, cigarette appeal is further limited.


The mint-flavored vaping ban that took effect in April 2022 did not include e-cigarettes. However, it has been reported that the FDA has rejected some pre-market tobacco product applications (PMTAs) for mint-flavored e-cigarettes. The e-cigarette manufacturers have appealed to the federal court in the United States, but the outcome of the appeal is currently unknown.


It’s worth noting that the power of each state in the United States is immense, and therefore the enforcement power of the FDA cannot reach each state. In fact, as of now, most states in the United States still allow the sale of flavored cigarettes and e-cigarettes, with only Washington D.C., Massachusetts, and California implementing a statewide ban on flavored tobacco. If flavored e-cigarettes are included, New York, New Jersey, and Rhode Island can also be added to the list. In addition, some cities and counties have implemented similar bans, such as Philadelphia, the capital of Pennsylvania, and Chicago, the largest city in Illinois.


Minnesota or Maine may become the next state to pass a flavored tobacco ban, following the progression of similar policies in other states. As two deep blue states, their policy approach aligns closely with California, where numerous cities and counties have already enacted flavor bans. Additionally, Minnesota currently holds the highest wholesale tax rate on e-cigarettes at 95%, making it a state to potentially avoid when strategizing market expansion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03